Anti-PI 3 Kinase p85 alpha antibody [EP380Y] - BSA and Azide free
- RabMAb
- Recombinant
- KO Validated
- What is this?
Be the first to review this product! Submit a review
|
(2 Publications)
Rabbit Recombinant Monoclonal PI 3 Kinase p85 alpha antibody. Carrier free. Suitable for WB and reacts with Human samples. Cited in 2 publications.
View Alternative Names
GRB1, PIK3R1, Phosphatidylinositol 3-kinase regulatory subunit alpha, PI3-kinase regulatory subunit alpha, PI3K regulatory subunit alpha, PtdIns-3-kinase regulatory subunit alpha, Phosphatidylinositol 3-kinase 85 kDa regulatory subunit alpha, PI3-kinase subunit p85-alpha, PtdIns-3-kinase regulatory subunit p85-alpha
- WB
Unknown
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] - BSA and Azide free (AB182617)
This data was developed using ab40755, the same antibody clone in a different buffer formulation.
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] (<a href='/en-us/products/primary-antibodies/pi-3-kinase-p85-alpha-antibody-ep380y-ab40755'>ab40755</a>) at 1/2000 dilution
Lane 1:
A431 cell lysate at 10 µg
Lane 2:
MCF-7 cell lysate at 10 µg
Lane 3:
Raji cell lysate at 10 µg
Predicted band size: 83 kDa
Observed band size: 85 kDa
false
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] - BSA and Azide free (AB182617)
This data was developed using ab40755, the same antibody clone in a different buffer formulation.
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : PI 3 Kinase p85 alpha knockout HAP1 cell lysate (20 μg)
Lane 3 : Jurkat cell lysate (20 μg)
Lane 4 : THP1 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab40755 observed at 90 kDa. Red - loading control, ab181602, observed at 37 kDa.
ab40755 was shown to recognize PI 3 Kinase p85 alpha in wild-type HAP1 cells along with additional cross-reactive bands. No Band was observed when PI 3 Kinase p85 alpha knockout samples were examined. Wild-type and PI 3 Kinase p85 alpha knockout samples were subjected to SDS-PAGE. ab40755 and ab181602 (loading control to GAPDH) were diluted 1/1000 and 1/2000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10,000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] (<a href='/en-us/products/primary-antibodies/pi-3-kinase-p85-alpha-antibody-ep380y-ab40755'>ab40755</a>)
Predicted band size: 83 kDa
false
- WB
Lab
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] - BSA and Azide free (AB182617)
This data was developed using ab182617, the same antibody clone in a different buffer formulation. Blocking and diluting buffer and concentration : 5% NFDM/TBST.
Lysates were freshly made and used for Western blotting immediately to minimize protein degradation.
Compared with ab40755, ab191606 has higher sensitivity. We recommend ab124805 as an alternative for testing western blot.
We suggest optimizing experimental protocols (increasing lysate amount, using lower dilution or higher sensitivity ECL substrate) to improve results when using ab197896 in western blot.
Lane 1:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EP380Y] (<a href='/en-us/products/primary-antibodies/pi-3-kinase-p85-alpha-antibody-ep380y-ab40755'>ab40755</a>) at 1/1000 dilution
Lane 2:
Western blot - Anti-PI 3 Kinase p85 alpha antibody [EPR18702] (<a href='/en-us/products/primary-antibodies/pi-3-kinase-p85-alpha-antibody-epr18702-ab191606'>ab191606</a>) at 1/1000 dilution
All lanes:
Jurkat (human T cell leukemia T lymphocyte) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Observed band size: 85 kDa
false
Exposure time: 40s
Related conjugates and formulations (1)
-
Anti-PI 3 Kinase p85 alpha antibody [EP380Y]
Reactivity data
Product details
ab182617 is the carrier-free version of ab40755.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Conjugation ready
Our carrier-free antibodies are typically supplied in a PBS-only formulation, purified and free of BSA, sodium azide and glycerol. This conjugation-ready format is designed for use with fluorochromes, metal isotopes, oligonucleotides, and enzymes, which makes them ideal for antibody labelling, functional and cell-based assays, flow-based assays (e.g. mass cytometry) and Multiplex Imaging applications.
Use our conjugation kits for antibody conjugates that are ready-to-use in as little as 20 minutes with 1 minute hands-on-time and 100% antibody recovery: available for fluorescent dyes, HRP, biotin and gold.
Compatibility
This product is compatible with the Maxpar® Antibody Labeling Kit from Fluidigm, without the need for antibody preparation. Maxpar® is a trademark of Fluidigm Canada Inc.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
P85 alpha modulates intracellular signaling by interacting with other proteins in a complex formation with catalytic subunit p110. This interaction enables the initiation of downstream signaling cascades controlling cell growth proliferation and survival. PI 3 kinase activity mediated by p85 alpha is integral to cellular homeostasis and metabolism helping to execute cellular responses to a variety of growth factors and hormones.
Pathways
PI 3 Kinase p85 alpha integrates into two principal signaling networks: the PI3K-Akt and mTOR pathways. These pathways are instrumental for regulating anabolic processes and cell survival. The p85 form of PI3K interacts with additional proteins such as Akt and mTOR coordinating cellular energy balance promoting protein synthesis and inhibiting apoptosis. Through these interactions the protein ensures that cells respond accurately to nutritional and stress signals.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (2)
Recent publications for all applications. Explore the full list and refine your search
Allergologia et immunopathologia 53:74-81 PubMed40088025
2025
Applications
Unspecified application
Species
Unspecified reactive species
Stem cells and development 21:977-86 PubMed22182484
2012
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com